CellSeed Inc. (TYO:7776)

Japan flag Japan · Delayed Price · Currency is JPY
349.00
-5.00 (-1.41%)
At close: Mar 6, 2026
Market Cap12.90B -6.3%
Revenue (ttm)161.00M -19.1%
Net Income-914.00M
EPS-53.15
Shares Out36.97M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,171,500
Average Volume2,059,085
Open346.00
Previous Close354.00
Day's Range342.00 - 366.00
52-Week Range231.00 - 742.00
Beta1.14
RSI55.18
Earnings DateFeb 13, 2026

About CellSeed

CellSeed Inc. engages in the cell sheet regenerative medicine business in Japan. It is involved in the commercializing regenerative medicine using cell sheets. The company also offers cell cultureware services, and contract development and manufacturing services; UpCell, a temperature-responsive cell cultureware for cell sheet engineering; RepCell for cell collection; and HydroCell, a low cell binding cultureware. In addition, it provides ThermoPlate III, a heating element; cellZscope, an automated cell monitoring systems; and cell sheet suppor... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 44
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7776
Full Company Profile

Financial Performance

In 2021, CellSeed's revenue was 161.00 million, a decrease of -19.10% compared to the previous year's 199.00 million. Losses were -914.00 million, 16.7% more than in 2020.

Financial Statements